Transferring functional immune responses to pathogens after haploidentical hematopoietic transplantation. - Wikidata - awgldk - TriplyDB

Transferring functional immune responses to pathogens after haploidentical hematopoietic transplantation.

Transferring functional immune responses to pathogens after haploidentical hematopoietic transplantation.

http://www.wikidata.org/entity/Q41978755

about

Role of germination in murine airway CD8(+) T-cell responses to Aspergillus conidia Aspergillus fumigatus: principles of pathogenesis and host defense Review on Haploidentical Hematopoietic Cell Transplantation in Patients with Hematologic Malignancies Adoptive T-cell therapy for fungal infections in haematology patients Alternative Donor Transplantation for Acute Myeloid Leukemia Monitoring of pathogen-specific T-cell immune reconstitution after allogeneic hematopoietic stem cell transplantation Antiviral T-cell therapy Immunity to Infections after Haploidentical Hematopoietic Stem Cell Transplantation The immune interplay between the host and the pathogen in Aspergillus fumigatus lung infection Eosinophils are recruited in response to chitin exposure and enhance Th2-mediated immune pathology in Aspergillus fumigatus infection Bioengineering T cells to target carbohydrate to treat opportunistic fungal infection.Improving cytomegalovirus-specific T cell reconstitution after haploidentical stem cell transplantation T-cell-based therapies for malignancy and infection in childhood.Induction of A. fumigatus-specific CD4-positive T cells in patients recovering from invasive aspergillosis.Haplo is the new black.Radiosensitive severe combined immunodeficiency disease.Aspergillus fumigatus: contours of an opportunistic human pathogen.Distinct and complementary roles for Aspergillus fumigatus-specific Tr1 and Foxp3+ regulatory T cells in humans and mice.Haploidentical vs cord blood transplantation for adults with acute myelogenous leukemia.Activity of broad-spectrum T cells as treatment for AdV, EBV, CMV, BKV, and HHV6 infections after HSCT.Adoptive transfer of unselected or leukemia-reactive T-cells in the treatment of relapse following allogeneic hematopoietic cell transplantation.A panel of artificial APCs expressing prevalent HLA alleles permits generation of cytotoxic T cells specific for both dominant and subdominant viral epitopes for adoptive therapy.Characterization of specific immune responses to different Aspergillus antigens during the course of invasive Aspergillosis in hematologic patients Epidemiology and treatment approaches in management of invasive fungal infections Strategies to harness immunity against infectious pathogens after haploidentical stem cell transplantation Inducible caspase-9 suicide gene controls adverse effects from alloreplete T cells after haploidentical stem cell transplantation CD4(+) T cell vaccination overcomes defective cross-presentation of fungal antigens in a mouse model of chronic granulomatous disease.Definition and characterization of novel HLA-*A02-restricted CD8+ T cell epitopes derived from JCV polyomavirus with clinical relevance.Insights and hopes in umbilical cord blood stem cell transplantations Preparing clinical grade Ag-specific T cells for adoptive immunotherapy trials.Anti-CD45 radioimmunotherapy without TBI before transplantation facilitates persistent haploidentical donor engraftment Alternative donor transplants for adult acute lymphoblastic leukaemia: a comparison of the three major options.Strategies to enhance immune function in hematopoietic transplantation recipients who have fungal infections.Immunological aspects of Candida and Aspergillus systemic fungal infections.Management of acute graft-versus-host disease.Haploidentical transplantation for hematologic malignancies: where do we stand?Immunologic special forces: anti-pathogen cytotoxic T-lymphocyte immunotherapy following hematopoietic stem cell transplantation.Adoptive cellular immunotherapy for childhood malignancies.Searching for alternative hematopoietic stem cell donors for pediatric patients.Haploidentical haematopoietic stem cell transplantation for acute leukaemia in adults: experience in Europe and the United States.

P2860

Q23921895-5905B7CB-3C36-4924-889E-499BD3C12A87 Q24681995-3CC13FA3-B32F-4086-8BCC-9129B5AC42F1 Q26749120-22DEE1BE-739B-4AD8-BCB4-1C68C1537874 Q26781064-E3FDC9DF-8D87-4181-A887-B0B76B8825E4 Q26799456-0D0725BB-3329-46AC-9ACF-0D61405E5751 Q26861648-3B821E11-4DE4-4F0F-AAA8-FE8216597568 Q27028006-6442E243-9BD6-432C-9975-DD203CB647C4 Q28079606-366351BF-69D4-4A31-8C00-0352197019D4 Q28387394-F1CDBCCB-501C-4A00-9049-B1F6762DA3CB Q28392563-ADF4FF9F-B1C6-4FA6-8E6E-1353B8D22555 Q30585324-8AEA41BE-A58F-475E-9D66-E3387AD07F7F Q33597783-E0600E41-F7C2-4DE1-872C-2230267B100B Q33750862-21F9A0FA-677C-4E5B-8E74-37BFD3CAB2DF Q33828598-0A73FDE0-7DB6-4B53-9DBD-573F1600099D Q33987066-B214B9F8-5408-4B3F-B957-4107F9E224CE Q34095701-A0847556-7F51-4831-902C-008D6F326174 Q34131696-2D41B020-15A4-4472-8D89-AABF81A655A6 Q34207966-FAE84582-145D-42A4-BA8D-F8AEDA419F92 Q34232835-D47A940E-D3A8-4B93-AC56-A4E3ABAFBD1C Q34273968-E95EFB3A-8B02-4358-90D3-A0615CEE6945 Q34279672-C3FAE915-E6AB-4B04-B622-FB7D3F2D4DF1 Q34815702-D3EFF594-3F97-47D4-9CE9-348E9EC452EF Q34984670-7E8A942B-72E7-48F1-B79B-467A7648A5A8 Q35089772-237DCCD4-4057-4F83-BC3F-6CC6AC0BED4B Q35485612-9B58B692-08C0-407B-BE24-C006371409FD Q35784529-CF24B7EB-0A17-4D6E-B766-090DCDAABDDB Q35913715-B8D2253C-2ACC-4B6E-A6A0-346A5DAA2B27 Q36153492-4D3C4814-701F-4F99-B4C5-3C585B4B37A2 Q36432837-B46376FD-A8C4-45A4-81A4-94A67C0A5FE8 Q36453570-395A3BC1-519C-40FE-998A-4E713281B673 Q36488985-4CCDBAA1-0913-4B2D-A217-F15575D4AC03 Q36557963-2A88B006-CD7E-421F-9A2F-D8B2B293CC5E Q36568458-947EB72E-B418-475F-8891-1807C02D1CA5 Q36587261-76DE6B44-A4BB-496A-B224-C3DCC0788C59 Q36773002-B7002F99-FC61-430C-842E-28F34DBC6787 Q36854831-81C64D73-AB96-491F-A049-7718DB19C8F1 Q36956443-03E02A3B-EBC5-4B57-BC2B-FFC03DAF1621 Q37008216-E975C218-E27B-41EE-9686-144C1209EC82 Q37033846-107A2176-51CF-4620-B26F-A470FD666FF1 Q37051052-8F97B823-B43D-47CA-8C18-CEA145110326

P2860

Transferring functional immune responses to pathogens after haploidentical hematopoietic transplantation.

http://www.wikidata.org/entity/Q41978755

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

2005年论文

@zh

2005年论文

@zh-cn

name

Transferring functional immune ...... hematopoietic transplantation.

@en

type

label

Transferring functional immune ...... hematopoietic transplantation.

@en

prefLabel

Transferring functional immune ...... hematopoietic transplantation.

@en

P1433

Q41978755-6FBBFFF0-032C-49B1-A563-611F92A505EC

P1476

Q41978755-AC549FC4-E0B7-40E6-A752-9B684AF53749

P2093

Q41978755-35E70EF4-523C-423A-9C2E-F6E0B0F1BC39

Q41978755-5729D5BF-4F75-4A69-87F0-122604221BCB

Q41978755-93D2EFA7-6EF3-49CD-ACE7-8E68CA9A6B7B

Q41978755-9E14FAB5-F218-4DBE-A1DA-022DFA21A989

Q41978755-A4AEB553-DE18-47EF-8824-5F713919D628

Q41978755-AD2E02D8-79D5-461C-AB39-CBE013810375

Q41978755-C7CA5F86-E489-445D-A1E3-13C1AC9144E5

Q41978755-CA233DF6-0A7E-44A8-B6FE-8163C5F6FCD6

Q41978755-D6DC838F-2BFC-481A-B8FD-AEAE6CEF0E92

Q41978755-EF57FACD-8866-4BFD-8DBF-593760A9BA0D

P2860

Q41978755-0127E325-9D64-4F4B-8296-5C909F14C7A6

Q41978755-0CA6240A-85EC-46A2-A52B-D8C3827D4CAA

Q41978755-11D80B6E-98ED-4BB2-B87E-66E827B9369A

Q41978755-18ED6C29-8E5E-42D8-9999-99A35A84A182

Q41978755-260FFB2F-54F8-4EC6-A1D9-150F7585B1F5

Q41978755-2FFB77AA-5CDD-4855-B1EF-33C378D6919F

Q41978755-43B238E8-E517-4771-AB96-AB25636DF3BD

Q41978755-6A13E1C1-09CF-4F01-A9EE-8BCF381167FB

Q41978755-6B9CD9CA-884B-49D5-A6A7-B4C59F722991

Q41978755-73CCD1B6-14FC-48E4-9A05-21219A8E8F15

P304

Q41978755-338BA619-8A55-44BF-AAE1-785C7FD373DE

P31

Q41978755-CA5A8A00-49EA-4522-A4D9-BCC1EEF4E543

P356

Q41978755-57E9C214-7A1B-4A72-B184-F4E26A70B7FB

P407

Q41978755-591A2F23-B33B-4FE1-9D20-528480DFD650

P433

Q41978755-1FBBB1C1-4243-45D1-9933-3D827EABF415

P478

Q41978755-ADC58F7A-8DB4-4EEA-91E7-3B26EACF10A4

P50

Q41978755-5C4CF7DF-E44B-449C-83E0-ED0EBD26529A

Q41978755-FD0C5759-DE29-4613-880B-831D44B3D8D8

P577

Q41978755-33B98D80-82C5-44FE-B624-2A6D4C2343EB

P698

Q41978755-D84252F8-5895-4A7F-8540-C1A32C6ECFA3

P932

Q41978755-AF07EE73-B1FE-4E40-BC33-BEBB29214740

P356

BLOOD-2005-05-1775

P1433

P1476

Transferring functional immune ...... hematopoietic transplantation.

@en

P2093

Alessandra Carotti

http://www.w3.org/2001/XMLSchema#string

Andrea Velardi

http://www.w3.org/2001/XMLSchema#string

Antonella Mancusi

http://www.w3.org/2001/XMLSchema#string

Antonella Tosti

http://www.w3.org/2001/XMLSchema#string

Elena Urbani

http://www.w3.org/2001/XMLSchema#string

Emanuela Burchielli

http://www.w3.org/2001/XMLSchema#string

Fabiana Topini

http://www.w3.org/2001/XMLSchema#string

Katia Perruccio

http://www.w3.org/2001/XMLSchema#string

Loredana Ruggeri

http://www.w3.org/2001/XMLSchema#string

Marusca Capanni

http://www.w3.org/2001/XMLSchema#string

P2860

Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes

Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants

Infections in bone marrow transplant recipients.

Increased transplant-related morbidity and mortality in CMV-seropositive patients despite highly effective prevention of CMV disease after allogeneic T-cell-depleted stem cell transplantation.

Generation of cytomegalovirus (CMV)-specific CD4 T cell lines devoid of alloreactivity, by use of a mixture of CMV-phosphoprotein 65 peptides for reconstitution of the T helper repertoire.

Fungal infections after bone marrow transplant.

Inhibition of immune functions by antiviral drugs.

Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus.

Depletion of host Langerhans cells before transplantation of donor alloreactive T cells prevents skin graft-versus-host disease

Limiting dilution assays for the determination of immunocompetent cell frequencies. I. Data analysis.

P304

4397-4406

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1182/BLOOD-2005-05-1775

http://www.w3.org/2001/XMLSchema#string

P407

P433

13

http://www.w3.org/2001/XMLSchema#string

P478

106

http://www.w3.org/2001/XMLSchema#string

P50

P577

2005-08-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16123217

http://www.w3.org/2001/XMLSchema#string

P932

1895249

http://www.w3.org/2001/XMLSchema#string